
### [MONDO:0017410](http://purl.obolibrary.org/obo/MONDO_0017410)
**Label:** porencephaly

**Subclasses:** [MONDO:0013773](http://purl.obolibrary.org/obo/MONDO_0013773) (porencephaly 2), [MONDO:0008289](http://purl.obolibrary.org/obo/MONDO_0008289) (porencephaly 1), [MONDO:0020496](http://purl.obolibrary.org/obo/MONDO_0020496) (familial porencephaly), [MONDO:0017815](http://purl.obolibrary.org/obo/MONDO_0017815) (acquired porencephaly), 

**Corr. equiv. classes:** [OMIM:175780](http://purl.obolibrary.org/obo/OMIM_175780), [OMIM:614483](http://purl.obolibrary.org/obo/OMIM_614483), [Orphanet:99810](http://www.orpha.net/ORDO/Orphanet_99810), [Orphanet:314697](http://www.orpha.net/ORDO/Orphanet_314697), 

**Class expressions from DL-Learner:**

- [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) and [HP:0100659](http://purl.obolibrary.org/obo/HP_0100659) (Abnormality of the cerebral vasculature) 62.50%
- [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) and [HP:0100545](http://purl.obolibrary.org/obo/HP_0100545) (Arterial stenosis) 62.50%
- [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 62.50%
- [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) and [HP:0030319](http://purl.obolibrary.org/obo/HP_0030319) (Weakness of facial musculature) 62.50%
- [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 62.50%
- [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) and [HP:0011799](http://purl.obolibrary.org/obo/HP_0011799) (Abnormality of facial soft tissue) 62.50%
- [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) 62.50%
- [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) and [HP:0011004](http://purl.obolibrary.org/obo/HP_0011004) (Abnormal systemic arterial morphology) 62.50%
- [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) 62.50%
- [HP:0009145](http://purl.obolibrary.org/obo/HP_0009145) (Abnormal cerebral artery morphology) and [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) 62.50%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) 62.50%
- [HP:0003828](http://purl.obolibrary.org/obo/HP_0003828) (Variable expressivity) and [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) 62.50%
- [HP:0003812](http://purl.obolibrary.org/obo/HP_0003812) (Phenotypic variability) and [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) 62.50%
- [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) 62.50%
- [HP:0002637](http://purl.obolibrary.org/obo/HP_0002637) (Cerebral ischemia) and [HP:0010636](http://purl.obolibrary.org/obo/HP_0010636) (Schizencephaly) 62.50%


